The Beauty Health Company

The Beauty Health Co. engages in manufacturing and selling of serum-based hydradermabrasion systems and aesthetic products. The company was founded in 1997 and is headquartered in Long Beach, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

The Beauty Health Company reports robust Q4 earnings and eyes international expansion opportunities

The Beauty Health Company delivered strong financial results in Q4 2022, showcasing consistent growth and profitability across regions.
Despite challenges like lower system ASP and heavy investments, the company's strategic initiatives and financial strength position it well for future growth.
Opportunities in international expansion, product portfolio enhancement, and market growth present avenues for sustained success in 2023 and beyond.
With a focus on operational efficiency, market adaptability, and category leadership, The Beauty Health Company remains poised for continued growth and profitability.

The Beauty Health Company (SKIN) reports robust Q1 performance and optimistic outlook for 2023

The Beauty Health Company (SKIN) showcased strong Q1 performance despite challenges, with a positive outlook for the year. The company's growth strategy, including the Cyndea system launch and boosters attachment rates, positions it well for future success.

Beauty Health Co. reports strong Q2, eyes global growth opportunities

The Beauty Health Company delivered strong Q2 results, reaffirming guidance despite challenges with Syndeo issues and gross margin pressure.
The company's focus on innovation, market resilience, and strategic investments positions it well for future growth and product expansion.
Opportunities in international markets, product enhancements, and margin improvement strategies present avenues for sustained performance and profitability.
Addressing challenges with Syndeo issues and gross margin pressure while leveraging market strengths and opportunities will be key to the company's continued success.

Beauty Health Co. addresses Syndeo challenges, focuses on growth

The Beauty Health Company is navigating challenges with Syndeo while focusing on customer-centric strategies and operational excellence under new leadership. Despite financial setbacks, the company aims for cost savings and growth opportunities through strategic transformation and reaccelerating Syndeo adoption in the U.S.

The Beauty Health Company reports solid Q4 performance and eyes growth in China market

The Beauty Health Company's Q4 2023 performance reflects revenue growth driven by APAC and EMEA, with operational efficiency and cost savings initiatives.
Strategic strengths include a strong cash position, inventory optimization efforts, and growth opportunities in the Chinese market.
Challenges include quality control issues, revenue declines in certain regions, and short-term financial pressures to be managed effectively.
Opportunities lie in expanding product offerings in China, improving gross margins, and addressing quality concerns to drive sustainable growth.

The Beauty Health Company (SKIN) surpasses Q1 targets, eyes growth

SKIN's Q1 performance exceeded expectations, with strong revenue and EBITDA figures, driven by consumables growth and operational improvements.
While facing challenges in equipment sales and product costs, SKIN's focus on excellence and growth opportunities position the company well for the future.
Analyst inquiries highlighted areas for improvement, but Marla Beck's confidence in growth avenues underscores a positive outlook for SKIN.

The Beauty Health Company (SKIN) exceeds Q3 revenue guidance, navigates market challenges

SKIN's Q3 2024 performance showcased revenue above guidance, profitability, and strategic advancements in sales, operations, and innovation.
While facing revenue declines and market challenges, SKIN's focus on profitability, margin expansion, and operational effectiveness signals a commitment to long-term success.
Navigating challenges with a proactive approach and seizing growth opportunities can position SKIN for sustained success and market resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

The headline numbers for The Beauty Health Company (SKIN) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Compared to Estimates, The Beauty Health Company (SKIN) Q4 Earnings: A Look at Key Metrics

LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company, home to flagship brand Hydrafacial, reports full year and fourth quarter 2023 financial results.

BeautyHealth Reports Full Year and Fourth Quarter 2023 Financial Results

LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company Board of Directors has appointed Marla Beck as the Company's permanent President and Chief Executive Officer.

BeautyHealth Announces Appointment Of Marla Beck As Chief Executive Officer

LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company will now report fourth quarter and full year 2023 financial results on Tuesday, March 12, 2024.

BeautyHealth To Now Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024

LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company, home to flagship brand Hydrafacial, will report fourth quarter and full year 2023 financial results on February 29, 2024.

BeautyHealth to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024

NEW YORK , Jan. 16, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in The Beauty Health Company ("Beauty Health" or the "Company") (NASDAQ: SKIN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Beauty Health investors who were adversely affected by alleged securities fraud between May 10, 2022 and November 13, 2023.

SHAREHOLDER ALERT: Levi & Korsinsky Notifies The Beauty Health Company(SKIN) Investors of a Class Action Lawsuit and Upcoming Deadline

LOS ANGELES, CA / ACCESSWIRE / January 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Beauty Health Company ("BeautyHealth" or "the Company") (NASDAQ:SKIN) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 10, 2022 and November 13, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before January 15, 2024.

FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in The Beauty Health Company with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / January 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Beauty Health Company ("BeautyHealth" or "the Company") (NASDAQ:SKIN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 10, 2022 and November 13, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before January 15, 2024.

FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in The Beauty Health Company with Losses of $100,000 to Contact the Firm

NEW YORK , Jan. 14, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of The Beauty Health Company ("Beauty Health" or the "Company") (NASDAQ: SKIN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Beauty Health Company - SKIN

NEW YORK , Jan. 12, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of The Beauty Health Company. Shareholders who purchased shares of SKIN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of The Beauty Health Company of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 16, 2024 - (NASDAQ: SKIN)

LOS ANGELES, CA / ACCESSWIRE / January 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Beauty Health Company ("BeautyHealth" or "the Company") (NASDAQ:SKIN) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 10, 2022 and November 13, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before January 15, 2024.

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in The Beauty Health Company with Losses of $100,000 to Contact the Firm

NEW YORK , Jan. 11, 2024 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against The Beauty Health Company ("Beauty Health" or "the Company") (NASDAQ: SKIN) and certain of its officers. Class Definition: This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Beauty Health securities between May 10, 2022 and November 13, 2023, inclusive (the "Class Period").

FINAL SKIN DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Beauty Health Company Investors with Substantial Losses to Join the Class Action Lawsuit!

If you suffered losses exceeding $50,000 investing in Beauty Health securities between May 10, 2022 and November 13, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330  (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/SKIN.

BEAUTY HEALTH INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Beauty Health To Contact Him Directly To Discuss Their Options

NEW YORK , Jan. 11, 2024 /PRNewswire/ -- Attention The Beauty Health Company ("Beauty Health") (NASDAQ: SKIN) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased between May 10, 2022 and November 13, 2023. If you suffered a loss on your investment in Beauty Health, contact us about potential recovery by using the link below.

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Beauty Health Investors of a Lead Plaintiff Deadline of January 16, 2024

LOS ANGELES , Jan. 10, 2024 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against The Beauty Health Company ("Beauty Health" or the "Company") (NASDAQ: SKIN).

SKIN Investors Have Opportunity to Lead The Beauty Health Company Securities Fraud Lawsuit

LOS ANGELES, CA / ACCESSWIRE / January 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Beauty Health Company ("BeautyHealth" or "the Company") (NASDAQ:SKIN) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 10, 2022 and November 13, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before January 15, 2024.

FINAL DEADLINE THIS MONTH: The Schall Law Firm Encourages Investors in The Beauty Health Company with Losses to Contact the Firm

NEW YORK , Jan. 8, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of The Beauty Health Company (NASDAQ: SKIN) between May 10, 2022 and November 13, 2023, both dates inclusive (the "Class Period"), of the important January 16, 2024 lead plaintiff deadline.  SO WHAT: If you purchased Beauty Health securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

ROSEN, A LEADING NATIONAL FIRM, Encourages The Beauty Health Company Investors with Losses to Secure Counsel Before Important January 16 Deadline in Securities Class Action - SKIN

LOS ANGELES, CA / ACCESSWIRE / January 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Beauty Health Company ("BeautyHealth" or "the Company") (NASDAQ:SKIN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 10, 2022 and November 13, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before January 15, 2024.

DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in The Beauty Health Company with Losses to Contact the Firm

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Beauty Health To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 investing in Beauty Health securities between May 10, 2022 and November 13, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330  (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/SKIN.

BEAUTY HEALTH INVESTOR DEADLINE APPROACHING

LOS ANGELES, CA / ACCESSWIRE / January 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Beauty Health Company ("BeautyHealth" or "the Company") (NASDAQ:SKIN) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 10, 2022 and November 13, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before January 15, 2024.

SHAREHOLDER ACTION DEADLINE: The Schall Law Firm Encourages Investors in The Beauty Health Company with Losses to Contact the Firm

NEW YORK , Jan. 1, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of The Beauty Health Company (NASDAQ: SKIN) between May 10, 2022 and November 13, 2023, both dates inclusive (the "Class Period"), of the important January 16, 2024 lead plaintiff deadline.  SO WHAT: If you purchased Beauty Health securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

ROSEN, A RESPECTED AND LEADING FIRM, Encourages The Beauty Health Company Investors to Secure Counsel Before Important Deadline in Securities Class Action - SKIN

LOS ANGELES, CA / ACCESSWIRE / December 29, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Beauty Health Company ("BeautyHealth" or "the Company") (NASDAQ:SKIN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 10, 2022 and November 13, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before January 15, 2024.

IMPORTANT DEADLINE REMINDER: The Schall Law Firm Encourages Investors in The Beauty Health Company with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / December 26, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Beauty Health Company ("BeautyHealth" or "the Company") (NASDAQ:SKIN) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 10, 2022 and November 13, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before January 15, 2024.

INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in The Beauty Health Company with Losses to Contact the Firm

NEW YORK , Dec. 25, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of The Beauty Health Company (NASDAQ: SKIN) between May 10, 2022 and November 13, 2023, both dates inclusive (the "Class Period"), of the important January 16, 2024 lead plaintiff deadline.  SO WHAT: If you purchased BeautyHealth securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

ROSEN, NATIONAL TRIAL LAWYERS, Encourages The Beauty Health Company Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SKIN

LOS ANGELES, CA / ACCESSWIRE / December 22, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Beauty Health Company ("BeautyHealth" or "the Company") (NASDAQ:SKIN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 10, 2022 and November 13, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before January 15, 2024.

News for The Beauty Health Company Stock (SKIN)